Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Why not Avot? Sedley
2
Aug 05, 2009 11:08AM
1
Aug 05, 2009 11:26AM

Well, Avot may not be taken over by Google and that would be a good thing for us IMO. Avot seems to be an integral part of whatever is being planned for a larger enterprise. To loose it might jeopardize that plan. However, think about two things. One, is On2 sufficiently similar to Avot that the two can be said to be worth the same? Then we now have an idea of what Avot is worth. So the value ( in actual dollars) of PTSC's share of Avot is now much clearer. Two, consider if Google ( or a Yahoo Microsoft type entity) bought Avot and (instead of cash for the purchase) shares were exchanged and PTSC became connected and brought into the fold of this larger entity. What value would that be to PTSC and its bigger plan with "Crossflo"? What part of PTSC's plan would be of value to a larger entity? GLTAL

1
Aug 05, 2009 03:17PM
1
Aug 05, 2009 03:46PM
Share
New Message
Please login to post a reply